
No transactions found.
No annual data found.
Passage Bio Inc (PASG) Stock: Should You Buy the Dip For 125% Upside?
Sector Update: Health Care Stocks Softer Late Afternoon
Passage Bio Faces Tougher FDA Road After Trial Shift, Wedbush Says
Passage Bio Seen as Undervalued Despite FDA Setback, Oppenheimer Says